BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34406419)

  • 1. Compound heterozygous DCLRE1C mutations lead to clinically typical Severe Combined Immunodeficiency presenting with Graft Versus Host Disease.
    Mou W; Gao L; He J; Yin J; Xu B; Gui J
    Immunogenetics; 2021 Dec; 73(6):425-434. PubMed ID: 34406419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional analysis of naturally occurring DCLRE1C mutations and correlation with the clinical phenotype of ARTEMIS deficiency.
    Felgentreff K; Lee YN; Frugoni F; Du L; van der Burg M; Giliani S; Tezcan I; Reisli I; Mejstrikova E; de Villartay JP; Sleckman BP; Manis J; Notarangelo LD
    J Allergy Clin Immunol; 2015 Jul; 136(1):140-150.e7. PubMed ID: 25917813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe combined immunodeficiency (SCID) presenting in childhood, with agammaglobulinemia, associated with novel compound heterozygous mutations in DCLRE1C.
    Sundin M; Marits P; Ramme K; Kolios AGA; Nilsson J
    Clin Immunol; 2019 Mar; 200():16-18. PubMed ID: 30630113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Non-Coding Variant in DCLRE1C Results in Deregulated Splicing and Induces SCID Through the Generation of a Truncated ARTEMIS Protein That Fails to Support V(D)J Recombination and DNA Damage Repair.
    Strubbe S; De Bruyne M; Pannicke U; Beyls E; Vandekerckhove B; Leclercq G; De Baere E; Bordon V; Vral A; Schwarz K; Haerynck F; Taghon T
    Front Immunol; 2021; 12():674226. PubMed ID: 34220820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular analysis of T-B-NK+ severe combined immunodeficiency and Omenn syndrome cases in Saudi Arabia.
    Alsmadi O; Al-Ghonaium A; Al-Muhsen S; Arnaout R; Al-Dhekri H; Al-Saud B; Al-Kayal F; Al-Saud H; Al-Mousa H
    BMC Med Genet; 2009 Nov; 10():116. PubMed ID: 19912631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The many faces of Artemis-deficient combined immunodeficiency - Two patients with DCLRE1C mutations and a systematic literature review of genotype-phenotype correlation.
    Lee PP; Woodbine L; Gilmour KC; Bibi S; Cale CM; Amrolia PJ; Veys PA; Davies EG; Jeggo PA; Jones A
    Clin Immunol; 2013 Dec; 149(3):464-74. PubMed ID: 24230999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DCLRE1C (ARTEMIS) mutations causing phenotypes ranging from atypical severe combined immunodeficiency to mere antibody deficiency.
    Volk T; Pannicke U; Reisli I; Bulashevska A; Ritter J; Björkman A; Schäffer AA; Fliegauf M; Sayar EH; Salzer U; Fisch P; Pfeifer D; Di Virgilio M; Cao H; Yang F; Zimmermann K; Keles S; Caliskaner Z; Güner SÜ; Schindler D; Hammarström L; Rizzi M; Hummel M; Pan-Hammarström Q; Schwarz K; Grimbacher B
    Hum Mol Genet; 2015 Dec; 24(25):7361-72. PubMed ID: 26476407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The most frequent DCLRE1C (ARTEMIS) mutations are based on homologous recombination events.
    Pannicke U; Hönig M; Schulze I; Rohr J; Heinz GA; Braun S; Janz I; Rump EM; Seidel MG; Matthes-Martin S; Soerensen J; Greil J; Stachel DK; Belohradsky BH; Albert MH; Schulz A; Ehl S; Friedrich W; Schwarz K
    Hum Mutat; 2010 Feb; 31(2):197-207. PubMed ID: 19953608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unusual phenotype in patients with a hypomorphic mutation in the DCLRE1C gene: IgG hypergammaglobulinemia with IgA and IgE deficiency.
    Nahum A; Somech R; Shubinsky G; Levy J; Broides A
    Clin Immunol; 2020 Apr; 213():108366. PubMed ID: 32092471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic T-lymphocyte-associated protein 4-Ig effectively controls immune activation and inflammatory disease in a novel murine model of leaky severe combined immunodeficiency.
    Humblet-Baron S; Schönefeldt S; Garcia-Perez JE; Baron F; Pasciuto E; Liston A
    J Allergy Clin Immunol; 2017 Nov; 140(5):1394-1403.e8. PubMed ID: 28185879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omenn syndrome caused by a novel homozygous mutation in recombination activating gene 1.
    Benhsaien I; Essadssi S; Elkhattabi L; Bakhchane A; Abdelghaffar H; Bousfiha AA; Badou A; Barakat A
    Immunobiology; 2021 May; 226(3):152090. PubMed ID: 33964732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological assessment of a patient with Omenn syndrome resulting from compound heterozygous mutations in the RAG1 gene.
    Mou W; Yang Z; Wang X; Hei M; Wang Y; Gui J
    Immunogenetics; 2023 Aug; 75(4):385-393. PubMed ID: 37269334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA recombination defects in Kuwait: Clinical, immunologic and genetic profile.
    Al-Herz W; Massaad MJ; Chou J; Notarangelo LD; Geha RS
    Clin Immunol; 2018 Feb; 187():68-75. PubMed ID: 29051008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omenn syndrome due to ARTEMIS mutations.
    Ege M; Ma Y; Manfras B; Kalwak K; Lu H; Lieber MR; Schwarz K; Pannicke U
    Blood; 2005 Jun; 105(11):4179-86. PubMed ID: 15731174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical phenotype and gene diagnostic analysis of Omenn syndrome].
    Wang YQ; Cui YX; Feng J
    Zhonghua Er Ke Za Zhi; 2013 Jan; 51(1):64-8. PubMed ID: 23527934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GvHD-associated cytokine polymorphisms do not associate with Omenn syndrome rather than T-B- SCID in patients with defects in RAG genes.
    Haq IJ; Steinberg LJ; Hoenig M; van der Burg M; Villa A; Cant AJ; Middleton PG; Gennery AR
    Clin Immunol; 2007 Aug; 124(2):165-9. PubMed ID: 17572155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID.
    Schuetz C; Neven B; Dvorak CC; Leroy S; Ege MJ; Pannicke U; Schwarz K; Schulz AS; Hoenig M; Sparber-Sauer M; Gatz SA; Denzer C; Blanche S; Moshous D; Picard C; Horn BN; de Villartay JP; Cavazzana M; Debatin KM; Friedrich W; Fischer A; Cowan MJ
    Blood; 2014 Jan; 123(2):281-9. PubMed ID: 24144642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of a child with severe combined immunodeficiency due to variants of DCLRE1C gene].
    Xu X; Yan D; Yin J; Zheng J; Wang X; Shu J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2022 Jul; 39(7):743-748. PubMed ID: 35810434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel spontaneous deletion of artemis exons 10 and 11 in mice leads to T- and B-cell deficiency.
    Barthels C; Puchałka J; Racek T; Klein C; Brocker T
    PLoS One; 2013; 8(9):e74838. PubMed ID: 24069355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lentivirus Mediated Correction of Artemis-Deficient Severe Combined Immunodeficiency.
    Punwani D; Kawahara M; Yu J; Sanford U; Roy S; Patel K; Carbonaro DA; Karlen AD; Khan S; Cornetta K; Rothe M; Schambach A; Kohn DB; Malech HL; McIvor RS; Puck JM; Cowan MJ
    Hum Gene Ther; 2017 Jan; 28(1):112-124. PubMed ID: 27611239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.